SGD PHARMA INDIA PRIVATE LIMITED,,HYDERABAD vs. ITO WARD-3(1), HYDERABAD
In the result, the appeal of the assessee in ITA
ITA 477/HYD/2022[2018-19]Status: DisposedITAT Hyderabad21 Jan 2026AY 2018-19
Bench: Shri Ravish Sooda N D Shri Madhusudan Sawdiaआ.अपी.सं /Ita-Tp Nos.130 & 447/Hyd/2022 (िनधा"रण वष"/Assessment Years: 2017-18 & 2018-19) M/S. Sgd Pharma India Vs. Dy.Cit/I.T.O Private Limited, Ward/Circle 3 (1) Mahabubnagar Hyderabad Pan:Aadcc7815K (Appellant) (Respondent) िनधा""रती "ारा/Assessee By: Shri Aliasgar Rampurwala, Ca राज" व "ारा/Revenue By:: Smt. K. Haritha, Cit(Dr) सुनवाई की तारीख/Date Of Hearing: 17/12/2025 घोषणा की तारीख/Pronouncement: 21/01/2026 आदेश/Order Per Madhusudan Sawdia, A.M.:
For Appellant: Shri Aliasgar Rampurwala, CAFor Respondent: : Smt. K. Haritha, CIT(DR)
Section 143(2)Section 143(3)Section 144C(1)Section 144C(13)Section 153Section 43BSection 92C
Transfer Pricing Officer (“Ld. TPO”) under section 92CA(1) of the Act. The Ld. TPO, vide order dated
28.01.2021, proposed an upward adjustment of Rs.2,28,23,848/- in respect of the international transaction relating to interest on External Commercial Borrowings (“ECB”). Based on the said order, the Ld. AO passed a draft assessment order dated 13.04.2021. 5. Aggrieved